Surrogate endpoints for overall survival in advanced non-small-cell lung cancer patients with mutations of the epidermal growth factor receptor gene

Subsequent therapies confound the ability to discern the effect of first-line chemotherapy on overall survival (OS). We investigated whether progression-free survival (PFS), post-progression survival (PPS) and tumor response were valid surrogate endpoints for OS following first-line chemotherapy in...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: YOSHINO, REIKO, IMAI, HISAO, MORI, KEITA, TAKEI, KOUSUKE, TOMIZAWA, MAI, KAIRA, KYOICHI, YOSHII, AKIHIRO, TOMIZAWA, YOSHIO, SAITO, RYUSEI, YAMADA, MASANOBU
Format: Artigo
Idioma:Inglês
Publicat: D.A. Spandidos 2014
Matèries:
Articles
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4106738/
https://ncbi.nlm.nih.gov/pubmed/25054038
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/mco.2014.334
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars